References

    1. Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia. 2004; 45 (9): 1141-9114. PubMed | Google Scholar

    2. WHO Model List of essential medicines (revised April 2013). http://www.who.int/medicines/publications/essentialmedicines/18th_EML_Final_web_8Jul13.pdf.Accessed 16 September 2013.

    3. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005;64(7):1134-1138. PubMed | Google Scholar

    4. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1): 92-96. PubMed | Google Scholar

    5. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995; 333:1600-16007 DOI: 10 1056/NEJM199512143332404. PubMed | Google Scholar

    6. Roujeau JC. Syndromes de Lyell et de Stevens-Johnson. https://www.orpha.net/data/patho/Pro/fr/LyellStevensJohnson-FRfrPro12597.pdf.Accessed 16 September 2013. PubMed | Google Scholar

    7. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, et al. A severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000; 115(2):149-153. PubMed | Google Scholar

    8. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy ClinImmunol. 2004; 114(5):1209-1215. PubMed | Google Scholar

    9. Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol. 2004;123(5): 850-855. PubMed | Google Scholar

    10. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, et al. Autoimmune diseases of the skin, pathogenesis, diagnosis , management. Science. 1998; 282:490-493. PubMed | Google Scholar

    11. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994; 331(19):1272-1285. PubMed | Google Scholar